Coronavirus: Emergency planning for the drug supply chain

The FDA has outlined its expectations and actions regarding supply chain and inspections in China

picture of

Breaking News

AstraZeneca joins forces with Silence to develop siRNA therapeutics

Collaboration with Silence Therapeutics has been agreed to develop small interfering RNA therapeutics that act inside ...

Sartorius supports first coronavirus vaccine in clinical trials

CanSinoBIO and the Institute of Bioengineering in China have used Sartorius’ BIOSTAT STR single-use bioreactor system ...

SPI Pharma expands patient-friendly oral dosage forms

SPI Pharma has applied its proprietary manufacturing technology to address mannitol’s inherently poor compressibility

Nitrosamines: Information for Marketing Authorisation Holders

Nitrosamine impurities have been in the regulatory spotlight since they were discovered in several blood pressure ...

Pharmalex summarises COVID-19 candidates in development

Researchers, companies and regulators understand that while ensuring safety, efficacy and quality are still of critical ...

e-therapeutics launches anti-viral drug discovery initiative for COVID-19

UK-based e-therapeutics discusses the moral responsibility of business and reaches out for aid with a network-driven ...

John Baker: life sciences need to address the reproducibility crisis

The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...

Evonik develops fermentation-based collagen production

Germany-based company has developed an animal-free collagen production technique

Impact BioMedical looks at compounds that block coronavirus mechanisms

The coronavirus has presented a unique challenge to exploit a 'hand shake' docking site to human cellular membranes ...

The Lonza powder-in-capsule microdosing approach

Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...

IntelGenx: oral films are drug development’s patent trick

Exploiting improvements in bioavailability, the Canadian company has developed unique oral film technology to help ...

UK medical cannabis: quality under scrutiny

Andrew James, Marketing Director of Ellutia, explains how chromatography can uncover the potency of a batch of cannabis ...

Bora continues American expansion with GSK facility acquisition

Bora Pharmaceuticals has agreed to continue manufacturing the existing GSK product produced at the Canadian facility ...

Orion chooses Nanoform to improve bioavailability

Finnish pharmaceutical company Orion will utilise Nanoform’s proprietary CESS technology to improve the bi ...